Role of monoamine oxidase and cathecol-O-methyltransferase in the metabolism of renal dopamine

  • M. H. Fernandes
  • P. Soares-da-Silva
Conference paper
Part of the Journal of Neural Transmission book series (NEURAL SUPPL, volume 41)


Incubation of slices of rat renal cortex with 50 μM L-DOPA during 15 min resulted in the formation of dopamine and of its deaminated (3,4-dihydroxyphenylacetic acid; DOPAC), methylated (3-methoxytyramine; 3-MT) and deaminated plus methylated (homovanillic acid; HVA) metabolites. The presence of pargyline (100 μM) resulted in a 90% reduction in the formation of DOPAC and HVA; levels of dopamine and 3-MT were found to be significantly increased. A concentration dependent decrease in the formation of methylated metabolites was obtained in the presence of (10, 50 and 100 μM) tropolone (10–50% reduction) and (0.1, 0.5, 1.0 and 5.0 μM) RO 40-7592 (50–95% reduction). Ro 40-7592 was also found to significantly increase DOPAC (20–40%) and dopamine (10–30%) levels, whereas tropolone slightly increased DOPAC (10%) levels. These results show that deamination represents the major pathway in the metabolism of newly formed dopamine under in vitro experimental conditions in the rat kidney. In addition, only when MAO is inhibited does methylation appear to represent an alternative metabolic pathway.


Monoamine Oxidase Sodium Butyrate Homovanillic Acid COMT Inhibitor COMT Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Baines AD, Chan W (1980) Production of urine free dopamine from dopa: a micro-puncture study. Life Sci 26: 253–259.PubMedCrossRefGoogle Scholar
  2. Caramona MM, Soares-da-Silva P (1990) Evidence for an extraneuronal location of monoamine oxidase in renal tissues. Naunyn Schmiedebergs Arch Pharmacol 341: 411–413.PubMedCrossRefGoogle Scholar
  3. Fernandes MH, Soares-da-Silva P (1990) Effects of MAO-A and MAO-B selective inhibitors Ro 41-1049 and Ro 19-6327 on the deamination of newly-formed dopamine in the rat kidney. J Pharmacol Exp Ther 255: 1309–1313.PubMedGoogle Scholar
  4. Fernandes MH, Pestana M, Soares-da-Silva P (1991) Deamination of newly-formed dopamine in rat renal tissues. Br J Pharmacol 102: 778–782.PubMedGoogle Scholar
  5. Fernandes MH, Soares-da-Silva P (1992) Type A and B monoamine oxidase activities in the human and rat kidney. Acta Physiol Scand 145: 363–367.PubMedCrossRefGoogle Scholar
  6. Kopin IJ (1985) Catecholamine metabolism: basic aspects and clinical significance. Pharmacol Rev 37: 333–364.PubMedGoogle Scholar
  7. Siragy HM, Felder RA, Howell NL, Chevalier RL, Peach MJ, Carey RM (1989) Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule. Am J Physiol 257: F469–F477.PubMedGoogle Scholar
  8. Soares-da-Silva P, Garrett MC (1990) A kinetic study of the rate of formation of dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the rat brain: implications for the origin of DOPAC. Neuropharmacology 29: 869–874.PubMedCrossRefGoogle Scholar
  9. Zurcher G, Keller HH, Getier R, Borgulya J, Bonetti EP, Eigenmann R, Da Prada M (1990) Ro 40-7592, a novel, very potent, and orally active inhibitor of caytechol-O-methyltransferase: a pharmacological study in rats. Adv Neurol 53: 497–503.PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • M. H. Fernandes
    • 1
  • P. Soares-da-Silva
    • 1
  1. 1.Department of Pharmacology and TherapeuticsFaculty of MedicinePortoPortugal

Personalised recommendations